Bristol-Myers Squibb Co’s top shareholder Wellington Management said on Wednesday it does not support the U.S. drugmaker’s $74 billion deal to buy biotech Celgene Corp, imperiling what would be the largest pharmaceutical acquisition of all time.
An experimental drug could offer hope for restoring damaged brain cells in Parkinson’s patients, scientists said on Wednesday, although they cautioned that a clinical trial was not able to prove the treatment slowed or halted the neurodegenerative disease.
Brazil’s health agency has concluded a re-evaluation of the safety of the weedkiller glyphosate, the most widely-used agriculture chemical in the country, and will present the findings and recommended guidelines for its future use on Tuesday, an official...
A global coalition set up to fight emerging epidemics has struck a $31 million deal with scientists at Japan’s University of Tokyo to speed up work on a vaccine against a brain-damaging disease caused by the Nipah virus.
Authorities in the United States have charged a man accused of leaking information on thousands of HIV victims in Singapore with possession and unlawful transfer of stolen documents.